SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-062637
Filing Date
2012-11-14
Accepted
2012-11-14 16:37:31
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v327335_10q.htm 10-Q 706678
2 EXHIBIT 10.1 v327335_ex10-1.htm EX-10.1 720784
3 EXHIBIT 31.1 v327335_ex31-1.htm EX-31.1 10250
4 EXHIBIT 31.2 v327335_ex31-2.htm EX-31.2 10151
5 EXHIBIT 32.1 v327335_ex32-1.htm EX-32.1 3917
6 EXHIBIT 32.2 v327335_ex32-2.htm EX-32.2 3892
  Complete submission text file 0001144204-12-062637.txt   5002322

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tgtxd-20120930.xml EX-101.INS 424822
8 XBRL TAXONOMY EXTENSION SCHEMA tgtxd-20120930.xsd EX-101.SCH 54480
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtxd-20120930_cal.xml EX-101.CAL 35763
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtxd-20120930_def.xml EX-101.DEF 229952
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtxd-20120930_lab.xml EX-101.LAB 382386
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtxd-20120930_pre.xml EX-101.PRE 278757
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 121205279
SIC: 2834 Pharmaceutical Preparations